Literature DB >> 10544035

Site-specific mutagenesis of mistletoe lectin: the role of RIP activity in apoptosis.

M Langer1, B Möckel, J Eck, H Zinke, H Lentzen.   

Abstract

Recombinant mistletoe lectin (rML) belongs to the class of type II ribosome-inactivating proteins (RIP) composed of a catalytically active A-chain with rRNA N-glycosidase activity and a B-chain with carbohydrate binding properties. To investigate the contribution of the enzymatic activity of the rML A-chain to the observed cytotoxic and apoptotic effects, an rMLA E166Q R169Q molecule was developed by means of site-specific mutagenesis. Following heterologous expression, the activity of mutant rMLA was measured in a cell-free assay for rRNA-N-glycosidase activity. Moreover, after generation of heterodimer, the activities of mutant rML E166Q R169Q and rML wild type were determined in a cytotoxicity and apoptosis assay. Although the reduction of activity as measured in the cell-free RIP assay was more pronounced (factor 237) than in both cellular assays (factors 20-22), the data clearly indicate a close correlation between cytotoxicity, apoptosis, and the enzymatic activity of the rML A-chain. Thus, RIP activity is an essential feature of rML and therefore a prerequisite for its biological function as an anticancer agent. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544035     DOI: 10.1006/bbrc.1999.1610

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Plant ribosome-inactivating proteins type II induce the unfolded protein response in human cancer cells.

Authors:  C Horrix; Z Raviv; E Flescher; C Voss; M R Berger
Journal:  Cell Mol Life Sci       Date:  2010-09-16       Impact factor: 9.261

2.  Ribosome-inactivating protein and apoptosis: abrin causes cell death via mitochondrial pathway in Jurkat cells.

Authors:  Sriram Narayanan; Avadhesha Surolia; Anjali A Karande
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

3.  Aviscumine, a recombinant ribosomal inhibitor, increases the antitumor activity of natural killer cells.

Authors:  Gabriele Gamerith; Arno Amann; Bettina Schenk; Thomas Auer; Hans Lentzen; Dirk O Mügge; Katharina M Cima; Judith Löffler-Ragg; Wolfgang Hilbe; Heinz Zwierzina
Journal:  Oncol Lett       Date:  2017-08-31       Impact factor: 2.967

4.  Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAM.

Authors:  Yuchan Cai; Shudao Xiong; Yijie Zheng; Feifei Luo; Pei Jiang; Yiwei Chu
Journal:  Cell Mol Immunol       Date:  2011-05-16       Impact factor: 11.530

Review 5.  The immunomodulatory effect of plant lectins: a review with emphasis on ArtinM properties.

Authors:  Maria A Souza; Fernanda C Carvalho; Luciana P Ruas; Rafael Ricci-Azevedo; Maria Cristina Roque-Barreira
Journal:  Glycoconj J       Date:  2013-01-09       Impact factor: 2.916

6.  Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study.

Authors:  Uwe Trefzer; Ralf Gutzmer; Tabea Wilhelm; Florian Schenck; Katharina C Kähler; Volkmar Jacobi; Klaus Witthohn; Hans Lentzen; Peter Mohr
Journal:  J Immunother Cancer       Date:  2014-08-19       Impact factor: 13.751

7.  Recombinant mistletoe lectin induces p53-independent apoptosis in tumour cells and cooperates with ionising radiation.

Authors:  K Hostanska; V Vuong; S Rocha; M S Soengas; C Glanzmann; R Saller; S Bodis; M Pruschy
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.